This week, Congress will dive into rising prescription drug costs with a hearing in the Senate Finance Committee. The hearing will feature seven top drug manufacturer executives and will focus on rising drug prices and transparency, among other topics. The Finance Committee is also looking into insulin price increases, joining the House Oversight Committee in investigating a number of prescription drug price increases. We cover this and more in this week's preview, which you can find by clicking here.
Eli Greenspan is a Manager of Government Relations as ML Strategies. Before joining ML Strategies, Eli was a legislative correspondent for US Senator Martin Heinrich.